US EditionThe global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study - AMR Insights
Antibiotic resistance (ABR) can increase hospital costs, utility loss, and mortality risk per patient. Understanding these losses is crucial for tackling ABR efficiently. A study estimated the global economic burden of antibiotic-resistant infections and the potential for bacterial vaccines to mitigate this burden. Multidrug-resistant tuberculosis had the highest mean hospital cost attributable to ABR per patient, with carbapenem-resistant infec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
